SCHEMBL8975476

SCHEMBL8975476

Cc1c(C)c2c(c(C)c1O)/C(=N/O)CC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP3A4 P08684 2/20 0.50
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 1/20 0.50
FFAR1 O14842 7/20 0.42
PPARA Q07869 2/20 0.42
PPARG P37231 10/20 0.41
HRH3 Q9Y5N1 1/20 0.41
RXRA P19793 1/20 0.40
MPC2 O95563 2/20 0.39
CYP2C8 P10632 2/20 0.39
CYP2C9 P11712 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9631443 1.00 MEN1 (0.50) MEN1MAPTKMT2ATDP1CYP3A4
SCHEMBL8975480 1.00 MEN1 (0.50) MEN1MAPTKMT2ATDP1CYP3A4
SCHEMBL9633224 0.92 MEN1 (0.49) MEN1MAPTKMT2ATDP1CYP3A4
SCHEMBL9633227 0.92 MEN1 (0.49) MEN1MAPTKMT2ATDP1CYP3A4
SCHEMBL8459669 0.90 MEN1 (0.53) MEN1MAPTKMT2ATDP1CYP3A4
SCHEMBL9630812 0.88 MEN1 (0.45) MEN1MAPTKMT2ATDP1CYP3A4
SCHEMBL9630815 0.88 MEN1 (0.45) MEN1MAPTKMT2ATDP1CYP3A4
SCHEMBL9631993 0.88 MEN1 (0.45) MEN1MAPTKMT2ATDP1CYP3A4
SCHEMBL9632005 0.88 MEN1 (0.45) MEN1MAPTKMT2ATDP1CYP3A4
SCHEMBL9631311 0.87 CYP3A4 (0.46) MEN1MAPTKMT2ATDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5104888-A Anticholesterol or antidiabetic agents SANKYO COMPANY, LIMITED (JP) 1992-04-14 US claimed
EP-0207581-B1 THIAZOLIDINE DERIVATIVES, THEIR PREPARATION AND USE SANKYO COMPANY LIMITED (JP) 1990-09-12 EP claimed
EP-0207581-A2 Thiazolidine derivatives, their preparation and use SANKYO COMPANY LIMITED (JP) 1987-01-07 EP claimed
EP-0441605-B1 Thiazolidine derivatives with anti-diabetic activity, their preparation and their use SANKYO CO (JP) 1996-04-10 EP disclosed
US-5143930-A THIAZOLIDINE DERIVATIVES WITH ANTI-DIABETIC ACTIVITY, THEIR PREPARATION AND THEIR USE SANKYO COMPANY, LIMITED (JP) 1992-09-01 US disclosed
US-5104888-A Anticholesterol or antidiabetic agents SANKYO COMPANY, LIMITED (JP) 1992-04-14 US disclosed
EP-0207581-B1 THIAZOLIDINE DERIVATIVES, THEIR PREPARATION AND USE SANKYO COMPANY LIMITED (JP) 1990-09-12 EP disclosed
EP-0207581-A2 Thiazolidine derivatives, their preparation and use SANKYO COMPANY LIMITED (JP) 1987-01-07 EP disclosed